Emerging Therapeutic Biomarkers in Endometrial Cancer

Although clinical trials of molecular therapies targeting critical biomarkers (mTOR, epidermal growth factor receptor/epidermal growth factor receptor 2, and vascular endothelial growth factor) in endometrial cancer show modest effects, there are still challenges that might remain regarding primary/...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Peixin, Kaneuchi, Masanori, Konno, Yosuke, Watari, Hidemichi, Sudo, Satoko, Sakuragi, Noriaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693108/
https://www.ncbi.nlm.nih.gov/pubmed/23819113
http://dx.doi.org/10.1155/2013/130362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693108/
https://www.ncbi.nlm.nih.gov/pubmed/23819113
http://dx.doi.org/10.1155/2013/130362

Ejemplares similares